: Conducting comparative studies with existing treatments could provide insights into the advantages and limitations of GVH-267.
The night they infused GVH-267, Lena stayed in the lab, pretending to analyze flow cytometry data. Really, she was watching the clock. Hour one: no anaphylaxis. Hour six: no cytokine storm. Day three: Theo’s rash stopped spreading. GVH-267